跳至主要内容
临床试验/NCT03254914
NCT03254914已完成不适用

A Multi-center, Cluster-randomized, Prospective, Observational Study

Boryung Pharmaceutical Co., Ltd1 个研究点 分布在 1 个国家目标入组 3,554 人开始时间: 2017年8月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
3,554
试验地点
1
主要终点
Rate of reaching target blood pressure

研究概览

简要总结

The purpose of this study is to evaluate the effect of home blood pressure monitoring on controlling blood pressure and correlation between home blood pressure and clinic blood pressure in hypertensive patients receiving two or more concomitant antihypertensive agents including fimasartan

详细描述

A multi-center, cluster-randomized, prospective, observational study

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects who voluntarily signed informed consent for participating in this clinical study
  • Male and female over the age of 19
  • Hypertensive patients receiving two or more concomitant anti-hypertensive agents including fimasartan

排除标准

  • Renal dialysis patients.
  • Diabetic nephropathy patients taking angiotensin-converting enzyme inhibitor.
  • Severe renal disorder
  • Subjects with hereditary disorders of galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption.
  • Medical history with hypersensitivity to Fimasartan
  • Pregnant women or lactating female.
  • Participate in another clinical trial.

结局指标

主要结局

Rate of reaching target blood pressure

时间窗: 12 weeks after treatment

Rate of reaching target blood pressure after treatment for 12 weeks

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Fimasartan Optimal Reduction Targeting Elevated... | 临床试验